Ziana Gel
NDC Package 99207-300-30
Package Information
Ziana (clindamycin phosphate and tretinoin) gel is this combination medication is used to treat acne. This formulation utilizes a gel delivery system. Marketed by Bausch Health Us, Llc, this product is identified by NDC 99207-300 and is authorized under FDA application NDA050802.
Identification & Billing
- RxCUI: 882548 - clindamycin phosphate 1.2 % / tretinoin 0.025 % Topical Gel
- RxCUI: 882548 - clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel
- RxCUI: 882548 - clindamycin phosphate 1.2 % (clindamycin 1 % ) / tretinoin 0.025 % Topical Gel
- RxCUI: 882550 - ZIANA 1.2 % / 0.025 % Topical Gel
- RxCUI: 882550 - clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel [Ziana]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 99207 - Bausch Health Us, Llc
- 99207-300 - Ziana
- 99207-300-30 - 1 TUBE in 1 CARTON / 30 g in 1 TUBE
- 99207-300 - Ziana
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (99207-300). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 99207-300-30 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube of Ziana, a human prescription drug labeled by Bausch Health Us, Llc. This gel is formulated for topical use and contains clindamycin phosphate; tretinoin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us, Llc on December 01, 2006. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This combination medication is used to treat acne. It helps decrease the number and severity of acne pimples and helps pimples that do develop to heal more quickly. Tretinoin belongs to a class of medications called retinoids. It works by affecting the growth of skin cells. Clindamycin is an antibiotic that stops the growth of bacteria that cause acne.
How is this Bausch Health Us, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 99207030030. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.